The U.S. Food and Drug Administration today approved Soliris (eculizumab) injection for intravenous use for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Neuromyelitis Optica Drug industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Glucocorticoids
Immunotherapies
Other
Market Segment by Product Application
Acute attack
Remission Prophylactic Treatment
Finally, the report provides detailed profile and data information analysis of leading company.
Pfizer
Fresenius
Teva
Sandoz
Intas
Gyjtrs
NANG KUANG
Tianjin Kingyork
Baxter
CSL
Grifols
Octapharma
CBOP
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Neuromyelitis Optica Drug consumption (value) by key regions/countries, product type and application, history data from 2016 to 2020, and forecast to 2026.
2.To understand the structure of Neuromyelitis Optica Drug market by identifying its various subsegments.
3.Focuses on the key global Neuromyelitis Optica Drug manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Neuromyelitis Optica Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Neuromyelitis Optica Drug submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Neuromyelitis Optica Drug Market Research Report 2021, Forecast to 2026
1 Market Study Overview
1.1 Study Objectives
1.2 Neuromyelitis Optica Drug Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Neuromyelitis Optica Drug Segment by Type
2.1.1 Glucocorticoids
2.1.2 Immunotherapies
2.1.3 Other
2.2 Market Analysis by Application
2.2.1 Acute attack
2.2.2 Remission Prophylactic Treatment
2.3 Global Neuromyelitis Optica Drug Market Comparison by Regions (2016-2026)
2.3.1 Global Neuromyelitis Optica Drug Market Size (2016-2026)
2.3.2 North America Neuromyelitis Optica Drug Status and Prospect (2016-2026)
2.3.3 Europe Neuromyelitis Optica Drug Status and Prospect (2016-2026)
2.3.4 China Neuromyelitis Optica Drug Status and Prospect (2016-2026)
2.3.5 Japan Neuromyelitis Optica Drug Status and Prospect (2016-2026)
2.3.6 Southeast Asia Neuromyelitis Optica Drug Status and Prospect (2016-2026)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Neuromyelitis Optica Drug Industry Impact
2.5.1 Neuromyelitis Optica Drug Business Impact Assessment - Covid-19
2.5.2 Market Trends and Neuromyelitis Optica Drug Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Neuromyelitis Optica Drug Sales and Market Share by Manufacturer (2016-2021)
3.2 Global Neuromyelitis Optica Drug Revenue and Market Share by Manufacturer (2016-2021)
3.3 Global Neuromyelitis Optica Drug Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Neuromyelitis Optica Drug Manufacturer Market Share
3.5 Top 10 Neuromyelitis Optica Drug Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Neuromyelitis Optica Drug Market
3.7 Key Manufacturers Neuromyelitis Optica Drug Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Neuromyelitis Optica Drug Industry Key Manufacturers
4.1 Pfizer
4.1.1 Compan Detail
4.1.2 Pfizer Neuromyelitis Optica Drug Product Introduction, Application and Specification
4.1.3 Pfizer 165 Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.1.4 Main Business Overview
4.1.5 Pfizer News
4.2 Fresenius
4.2.1 Compan Detail
4.2.2 Fresenius Neuromyelitis Optica Drug Product Introduction, Application and Specification
4.2.3 Fresenius Neuromyelitis Optica Drug Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.2.4 Main Business Overview
4.2.5 Pfizer News
4.3 Teva
4.3.1 Compan Detail
4.3.2 Teva Neuromyelitis Optica Drug Product Introduction, Application and Specification
4.3.3 Teva Neuromyelitis Optica Drug Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.3.4 Main Business Overview
4.3.5 Teva News
4.4 Sandoz
4.4.1 Compan Detail
4.4.2 Sandoz Neuromyelitis Optica Drug Product Introduction, Application and Specification
4.4.3 Sandoz Neuromyelitis Optica Drug Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.4.4 Main Business Overview
4.4.5 Sandoz News
4.5 Intas
4.5.1 Compan Detail
4.5.2 Sandoz Neuromyelitis Optica Drug Product Introduction, Application and Specification
4.5.3 Intas Neuromyelitis Optica Drug Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.5.4 Main Business Overview
4.5.5 Intas News
4.6 Gyjtrs
4.6.1 Compan Detail
4.6.2 Gyjtrs Neuromyelitis Optica Drug Product Introduction, Application and Specification
4.6.3 Gyjtrs Neuromyelitis Optica Drug Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.6.4 Main Business Overview
4.6.5 Gyjtrs News
4.7 NANG KUANG
4.7.1 Compan Detail
4.7.2 NANG KUANG Neuromyelitis Optica Drug Product Introduction, Application and Specification
4.7.3 NANG KUANG Neuromyelitis Optica Drug Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Tianjin Kingyork
4.8.1 Compan Detail
4.8.2 Tianjin Kingyork Neuromyelitis Optica Drug Product Introduction, Application and Specification
4.8.3 Tianjin Kingyork Neuromyelitis Optica Drug Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.8.4 Main Business Overview
4.8.5 Tianjin Kingyork News
4.9 Baxter
4.9.1 Compan Detail
4.9.2 Baxter Neuromyelitis Optica Drug Product Introduction, Application and Specification
4.9.3 Baxter Neuromyelitis Optica Drug Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.9.4 Main Business Overview
4.9.5 Baxter News
4.10 CSL
4.10.1 Compan Detail
4.10.2 CSL Neuromyelitis Optica Drug Product Introduction, Application and Specification
4.10.3 CSL Neuromyelitis Optica Drug Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.10.4 Main Business Overview
4.10.5 CSL News
4.11 Grifols
4.11.1 Compan Detail
4.11.2 Grifols Neuromyelitis Optica Drug Product Introduction, Application and Specification
4.11.3 Grifols Neuromyelitis Optica Drug Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.11.4 Main Business Overview
4.11.5 Grifols News
4.12 Octapharma
4.12.1 Compan Detail
4.12.2 Octapharma Neuromyelitis Optica Drug Product Introduction, Application and Specification
4.12.3 Octapharma Neuromyelitis Optica Drug Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.12.4 Main Business Overview
4.12.5 Octapharma News
4.13 CBOP
4.13.1 Company Details
4.13.2 CBOP Neuromyelitis Optica Drug Product Introduction, Application and Specification
4.13.3 CBOP Neuromyelitis Optica Drug Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.13.4 Main Business Overview
4.13.5 CBOP News
5 Global Neuromyelitis Optica Drug Market Segment by Big Type
5.1 Global Neuromyelitis Optica Drug Revenue, Sales and Market Share by Big Type (2016-2021)
5.1.1 Global Neuromyelitis Optica Drug Sales and Market Share by Big Type (2016-2021)
5.1.2 Global Neuromyelitis Optica Drug Revenue and Market Share by Big Type (2016-2021)
5.2 Glucocorticoids Sales Growth Rate and Price
5.2.1 Global Glucocorticoids Sales Growth Rate (2016-2021)
5.2.2 Global Glucocorticoids Price (2016-2021)
5.3 Immunotherapies Sales Growth Rate and Price
5.3.1 Global Immunotherapies Sales Growth Rate (2016-2021)
5.3.2 Global Immunotherapies Price (2016-2021)
5.4 Other Sales Growth Rate and Price
5.4.1 Global Other Sales Growth Rate (2016-2021)
5.4.2 Global Other Price (2016-2021)
6 Global Neuromyelitis Optica Drug Market Segment by Big Application
6.1 Global Neuromyelitis Optica Drug Sales Market Share by Big Application (2016-2021)
6.2 Acute attack Sales Growth Rate (2016-2021)
6.3 Remission Prophylactic Treatment Sales Growth Rate (2016-2021)
7 Global Neuromyelitis Optica Drug Forecast
7.1 Global Neuromyelitis Optica Drug Revenue, Sales and Growth Rate (2021-2026)
7.2 Neuromyelitis Optica Drug Market Forecast by Regions (2021-2026)
7.2.1 North America Neuromyelitis Optica Drug Market Forecast (2021-2026)
7.2.2 Europe Neuromyelitis Optica Drug Market Forecast (2021-2026)
7.2.3 China Neuromyelitis Optica Drug Market Forecast (2021-2026)
7.2.4 Japan Neuromyelitis Optica Drug Market Forecast (2021-2026)
7.2.5 Southeast Asia Neuromyelitis Optica Drug Market Forecast (2021-2026)
7.2.6 Other Regions Neuromyelitis Optica Drug Market Forecast (2021-2026)
7.3 Neuromyelitis Optica Drug Market Forecast by Type (2021-2026)
7.3.1 Global Neuromyelitis Optica Drug Sales Forecast by Type (2021-2026)
7.3.2 Global Neuromyelitis Optica Drug Market Share Forecast by Type (2021-2026)
7.4 Neuromyelitis Optica Drug Market Forecast by Application (2021-2026)
7.4.1 Global Neuromyelitis Optica Drug Sales Forecast by Application (2021-2026)
7.4.2 Global Neuromyelitis Optica Drug Market Share Forecast by Application (2021-2026)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Neuromyelitis Optica Drug Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Neuromyelitis Optica Drug Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Neuromyelitis Optica Drug
Figure Market Concentration Ratio and Market Maturity Analysis of Neuromyelitis Optica Drug
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Neuromyelitis Optica Drug Market Size by Big Type
Figure Global Market Share of Neuromyelitis Optica Drug by Big Type in 2020
Figure Glucocorticoids Picture (2016-2021)
Figure Immunotherapies Picture (2016-2021)
Global Neuromyelitis Optica Drug Market Size by Big Application
Table Global Neuromyelitis Optica Drug Market Size by Application
Figure Global Neuromyelitis Optica Drug Market Share by Big Application in 2020
Figure Acute attack Picture
Figure Remission Prophylactic Treatment Picture
Table Global Neuromyelitis Optica Drug Comparison by Regions (M USD) (2016-2026)
Figure Global Neuromyelitis Optica Drug Market Size (Million US$) (2016-2026)
Figure North America Neuromyelitis Optica Drug Revenue (Million US$) Growth Rate (2016-2026)
Figure Europe Neuromyelitis Optica Drug Revenue (Million US$) Growth Rate (2016-2026)
Figure China Neuromyelitis Optica Drug Revenue (Million US$) Growth Rate (2016-2026)
Figure Japan Neuromyelitis Optica Drug Revenue (Million US$) Growth Rate (2016-2026)
Figure Southeast Asia Neuromyelitis Optica Drug Revenue (Million US$) Growth Rate (2016-2026)
Table Business Impact Assessment - Covid-19
Table Market Trends and Neuromyelitis Optica Drug Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Neuromyelitis Optica Drug Sales by Manufacturer (2016-2021)
Figure Global Neuromyelitis Optica Drug Sales Market Share by Manufacturer in 2020
Table Global Neuromyelitis Optica Drug Revenue by Manufacturer (2016-2021)
Figure Global Neuromyelitis Optica Drug Revenue Market Share by Manufacturer in 2020
Table Global Neuromyelitis Optica Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Neuromyelitis Optica Drug Manufacturer (Revenue) Market Share in 2020
Figure Top 10 Neuromyelitis Optica Drug Manufacturer (Revenue) Market Share in 2020
Table Date of Key Manufacturers Enter into Neuromyelitis Optica Drug Market
Table Key Manufacturers Neuromyelitis Optica Drug Product Type
Table Mergers & Acquisitions Planning
Table Pfizer Company Profile
Table Neuromyelitis Optica Drug Product Introduction, Application and Specification of Pfizer
Table Neuromyelitis Optica Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2016-2021
Table Company One Main Business
Table Company One Recent Development
Table Fresenius Company Profile
Table Neuromyelitis Optica Drug Product Introduction, Application and Specification of Fresenius
Table Neuromyelitis Optica Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Fresenius Recent Development
Table Teva Company Profile
Table Neuromyelitis Optica Drug Product Introduction, Application and Specification of Teva
Table Neuromyelitis Optica Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Teva Main Business
Table Teva Recent Development
Table Sandoz Company Profile
Table Neuromyelitis Optica Drug Product Introduction, Application and Specification of Sandoz
Table Neuromyelitis Optica Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Sandoz Main Business
Table Sandoz Recent Development
Table Sandoz Main Business
Table Sandoz Recent Development
Table Intas Company Profile
Table Neuromyelitis Optica Drug Product Introduction, Application and Specification of Intas
Table Neuromyelitis Optica Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Intas Main Business
Table Intas Recent Development
Table Gyjtrs Company Profile
Table Neuromyelitis Optica Drug Product Introduction, Application and Specification of Gyjtrs
Table Neuromyelitis Optica Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Gyjtrs Main Business
Table Gyjtrs Recent Development
Table NANG KUANG Company Profile
Table Neuromyelitis Optica Drug Product Introduction, Application and Specification of NANG KUANG
Table Neuromyelitis Optica Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table NANG KUANG Main Business
Table NANG KUANG Recent Development
Table Tianjin Kingyork Company Profile
Table Neuromyelitis Optica Drug Product Introduction, Application and Specification of Tianjin Kingyork
Table Neuromyelitis Optica Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Tianjin Kingyork Main Business
Table Tianjin Kingyork Recent Development
Table Baxter Company Profile
Table Neuromyelitis Optica Drug Product Introduction, Application and Specification of Baxter
Table Neuromyelitis Optica Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Baxter Main Business
Table Baxter Recent Development
Table CSL Company Profile
Table Neuromyelitis Optica Drug Product Introduction, Application and Specification of CSL
Table Neuromyelitis Optica Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table CSL Main Business
Table CSL Recent Development
Table Grifols Company Profile
Table Neuromyelitis Optica Drug Product Introduction, Application and Specification of Grifols
Table Neuromyelitis Optica Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Grifols Main Business
Table Grifols Recent Development
Table Octapharma Company Profile
Table Neuromyelitis Optica Drug Product Introduction, Application and Specification of Octapharma
Table Neuromyelitis Optica Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Octapharma Main Business
Table Octapharma Recent Development
Table CBOP Company Profile
Table Neuromyelitis Optica Drug Product Introduction, Application and Specification of CBOP
Table Neuromyelitis Optica Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table CBOP Main Business
Table CBOP Recent Development
Figure Global Neuromyelitis Optica Drug Sales and Growth Rate (2016-2021)
Figure Global Neuromyelitis Optica Drug Revenue and Growth Rate (2016-2021)
Table Global Neuromyelitis Optica Drug Sales by Regions (2016-2021)
Figure Global Neuromyelitis Optica Drug Sales Market Share by Regions in 2020
Table Global Neuromyelitis Optica Drug Revenue by Regions (2016-2021)
Figure Global Neuromyelitis Optica Drug Revenue Market Share by Regions in 2020
Figure North America Neuromyelitis Optica Drug Sales and Growth Rate (2016-2021)
Figure Europe Neuromyelitis Optica Drug Sales and Growth Rate (2016-2021)
Figure China Neuromyelitis Optica Drug Sales and Growth Rate (2016-2021)
Figure Japan Neuromyelitis Optica Drug Sales and Growth Rate (2016-2021)
Figure Southeast Asia Neuromyelitis Optica Drug Sales and Growth Rate (2016-2021)
Figure Other Regions Neuromyelitis Optica Drug Sales and Growth Rate (2016-2021)
Table Global Neuromyelitis Optica Drug Sales by Big Type (2016-2021)
Table Global Neuromyelitis Optica Drug Sales Market Share by Big Type (2016-2021)
Figure Global Neuromyelitis Optica Drug Sales Market Share by Big Type in 2019
Table Global Neuromyelitis Optica Drug Revenue by Big Type (2016-2021)
Table Global Neuromyelitis Optica Drug Revenue Market Share by Big Type (2016-2021)
Table Global Neuromyelitis Optica Drug Revenue Market Share by Big Type in 2019
Figure Global Glucocorticoids Sales Growth Rate (2016-2021)
Figure Global Glucocorticoids Price (2016-2021)
Figure Global Immunotherapies Sales Growth Rate (2016-2021)
Figure Global Immunotherapies Price (2016-2021)
Figure Global Other Sales Growth Rate (2016-2021)
Table Global Neuromyelitis Optica Drug Sales by Big Application (2016-2021)
Table Global Neuromyelitis Optica Drug Sales Market Share by Big Application (2016-2021)
Figure Global Neuromyelitis Optica Drug Sales Market Share by Big Application in 2019
Figure Global Acute attack Sales Growth Rate (2016-2021)
Figure Global Remission Prophylactic Treatment Sales Growth Rate (2016-2021)
Figure Global Neuromyelitis Optica Drug Sales and Growth Rate (2021-2026)
Figure Global Neuromyelitis Optica Drug Revenue and Growth Rate (2021-2026)
Table Global Neuromyelitis Optica Drug Sales Forecast by Regions (2021-2026)
Table Global Neuromyelitis Optica Drug Market Share Forecast by Regions (2021-2026)
Figure North America Sales Neuromyelitis Optica Drug Market Forecast (2021-2026)
Figure Europe Sales Neuromyelitis Optica Drug Market Forecast (2021-2026)
Figure China Sales Neuromyelitis Optica Drug Market Forecast (2021-2026)
Figure Japan Sales Neuromyelitis Optica Drug Market Forecast (2021-2026)
Figure Southeast Asia Sales Neuromyelitis Optica Drug Market Forecast (2021-2026)
Figure Other Regions Sales Neuromyelitis Optica Drug Market Forecast (2021-2026)
Table Global Neuromyelitis Optica Drug Sales Forecast by Type (2021-2026)
Table Global Neuromyelitis Optica Drug Market Share Forecast by Type (2021-2026)
Table Global Neuromyelitis Optica Drug Sales Forecast by Application (2021-2026)
Table Global Neuromyelitis Optica Drug Market Share Forecast by Application (2021-2026)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neuromyelitis Optica Drug
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Neuromyelitis Optica Drug Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Neuromyelitis Optica Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Neuromyelitis Optica Drug Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Neuromyelitis Optica Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Neuromyelitis Optica Drug Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Neuromyelitis Optica Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Neuromyelitis Optica Drug Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Neuromyelitis Optica Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Pfizer
Fresenius
Teva
Sandoz
Intas
Gyjtrs
NANG KUANG
Tianjin Kingyork
Baxter
CSL
Grifols
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)